NASDAQ:BLLN Billiontoone (BLLN) Stock Price, News & Analysis $94.25 +3.13 (+3.44%) Closing price 06/2/2026 04:00 PM EasternExtended Trading$94.12 -0.13 (-0.13%) As of 08:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Billiontoone Stock (NASDAQ:BLLN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Billiontoone alerts:Sign Up Key Stats Today's Range$88.45▼$95.8550-Day Range$69.55▼$105.9452-Week Range$61.96▼$138.70Volume930,921 shsAverage Volume785,747 shsMarket Capitalization$4.33 billionP/E Ratio171.36Dividend YieldN/APrice Target$125.29Consensus RatingModerate Buy Company Overview BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical. BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics. Its technology aims to improve accuracy in detecting fetal aneuploidies, microdeletions, and single-gene disorders from maternal blood samples by reducing measurement noise and enabling precise digital quantification. The company provides testing services and partners with clinical laboratories, healthcare providers, and research organizations to implement its assays in clinical and research settings. In support of clinical adoption, BillionToOne focuses on analytical validation, clinical studies, and building laboratory processes that integrate its single-molecule counting approach into standard diagnostic pipelines. The company positions its platform as complementary to existing sequencing and molecular methods, emphasizing improved detection of low-frequency variants and potential reductions in false positives that can drive follow-up invasive procedures. BillionToOne serves the healthcare and clinical diagnostics market, primarily through collaborations and laboratory channels. Its management and scientific teams are oriented toward translating advanced genomic measurement techniques into deployable clinical tests, with ongoing efforts to expand the clinical utility and accessibility of its assays through partnerships and regulatory and clinical validation activities.AI Generated. May Contain Errors. Read More Billiontoone Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks96th Percentile Overall ScoreBLLN MarketRank™: Billiontoone scored higher than 96% of companies evaluated by MarketBeat, and ranked 3rd out of 61 stocks in the services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingBilliontoone has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 6 buy ratings, 3 hold ratings, and 1 sell rating.Upside PotentialBilliontoone has a consensus price target of $125.29, representing about 32.9% upside from its current price of $94.25.Amount of Analyst CoverageBilliontoone has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Billiontoone's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth15.05% Earnings GrowthEarnings for Billiontoone are expected to grow by 15.05% in the coming year, from $0.93 to $1.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Billiontoone is 171.36, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.61.Price to Earnings Ratio vs. SectorThe P/E ratio of Billiontoone is 171.36, which means that it is trading at a more expensive P/E ratio than the Services sector average P/E ratio of about 8.97.Price to Book Value per Share RatioBilliontoone has a P/B Ratio of 8.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.19% of the float of Billiontoone has been sold short.Short Interest Ratio / Days to CoverBilliontoone has a short interest ratio ("days to cover") of 1.57, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Billiontoone has recently decreased by 36.24%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBilliontoone does not currently pay a dividend.Dividend GrowthBilliontoone does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.97 News SentimentBilliontoone has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Services companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Billiontoone this week, compared to 4 articles on an average week.Search InterestOnly 8 people have searched for BLLN on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat Follows6 people have added Billiontoone to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Billiontoone insiders have not sold or bought any company stock.Percentage Held by InstitutionsBilliontoone has minimal institutional ownership at this time.Read more about Billiontoone's insider trading history. Receive BLLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Billiontoone and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLLN Stock News HeadlinesBilliontoone, Inc. (NASDAQ:BLLN) Short Interest Down 36.2% in May4 hours ago | americanbankingnews.comBillionToOne Touts Profitable Growth as Prenatal, Oncology Tests Gain TractionJune 3 at 3:09 AM | americanbankingnews.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.June 3 at 1:00 AM | InvestorPlace (Ad)BillionToOne to Participate in the William Blair 46th Annual Growth Stock ConferenceMay 27, 2026 | globenewswire.comBilliontoone, Inc. (NASDAQ:BLLN) Given Average Rating of "Moderate Buy" by BrokeragesMay 25, 2026 | americanbankingnews.comBillionToOne - Starting 2026 StrongMay 21, 2026 | seekingalpha.comJim Cramer on BillionToOne: “I Say Buy It”May 17, 2026 | finance.yahoo.comBillionToOne (BLLN) Stock Forecast & Price TargetMay 14, 2026 | investing.comSee More Headlines BLLN Stock Analysis - Frequently Asked Questions How have BLLN shares performed this year? Billiontoone's stock was trading at $81.84 at the beginning of the year. Since then, BLLN stock has increased by 15.2% and is now trading at $94.25. How were Billiontoone's earnings last quarter? Billiontoone, Inc. (NASDAQ:BLLN) posted its quarterly earnings data on Wednesday, May, 6th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.01 by $0.33. The firm's revenue was up 83.8% compared to the same quarter last year. Read the conference call transcript. When did Billiontoone IPO? Billiontoone (BLLN) raised $203 million in an initial public offering (IPO) on the week of November 3rd 2025. The company issued 3,900,000 shares at a price of $49.00-$55.00 per share. J.P. Morgan, Piper Sandler, Jefferies, William Blair, Stifel, Wells Fargo Securities and BTIG served as the underwriters for the IPO. When did the company's lock-up period expire? Billiontoone's lock-up period expired on Tuesday, May 5th. Billiontoone had issued 4,551,100 shares in its initial public offering on November 6th. The total size of the offering was $273,066,000 based on an initial share price of $60.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period. Who are Billiontoone's major shareholders? Billiontoone's top institutional investors include Wasatch Advisors LP (0.80%), Emerald Advisers LLC (0.52%), Emerald Mutual Fund Advisers Trust (0.29%) and Perceptive Advisors LLC (0.20%). How do I buy shares of Billiontoone? Shares of BLLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2026Today6/03/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorServices Industry Services – Health Sub-IndustryHealthcare Current SymbolNASDAQ:BLLN CIK2070849 WebN/A Phone(650) 460-2551FaxN/AEmployees620Year Founded2016Price Target and Rating Average Price Target for Billiontoone$125.29 High Price Target$150.00 Low Price Target$90.00 Potential Upside/Downside+32.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio171.36 Forward P/E Ratio101.34 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.18 Current Ratio10.92 Quick Ratio10.58 Sales & Book Value Annual Sales$305.11 million Price / Sales14.21 Cash Flow$0.33 per share Price / Cash Flow281.51 Book Value$10.48 per share Price / Book8.99Miscellaneous Outstanding Shares45,990,000Free FloatN/AMarket Cap$4.33 billion OptionableN/A BetaN/A Social Links 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:BLLN) was last updated on 6/3/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Billiontoone, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Billiontoone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
